Equities

Diamyd Medical AB

Diamyd Medical AB

Actions
  • Price (SEK)13.82
  • Today's Change-0.66 / -4.56%
  • Shares traded184.76k
  • 1 Year change+68.54%
  • Beta1.8848
Data delayed at least 15 minutes, as of Sep 23 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Aug 31 2023202320222021
ASSETS
Cash And Short Term Investments128160139
Total Receivables, Net4.672.451.65
Total Inventory------
Prepaid expenses8.611122
Other current assets, total--0.00--
Total current assets141173163
Property, plant & equipment, net52465.55
Goodwill, net------
Intangibles, net000.07
Long term investments111532
Note receivable - long term0.570.630.63
Other long term assets0.00----
Total assets206237201
LIABILITIES
Accounts payable4.899.785.57
Accrued expenses5.545.034.79
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total9.436.561.04
Total current liabilities202111
Total long term debt1600
Total debt1600
Deferred income tax------
Minority interest------
Other liabilities, total0.690.780.78
Total liabilities362212
SHAREHOLDERS EQUITY
Common stock8.707.807.26
Additional paid-in capital460391249
Retained earnings (accumulated deficit)(300)(184)(67)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total----0.00
Total equity169214189
Total liabilities & shareholders' equity206237201
Total common shares outstanding867973
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.